Swedish DPI developer Iconovo announced that Monash University has acquired exclusive global rights for the use of Iconovo's ICOone single dose DPI for delivery of Monash's inhaled oxytocin for the prevention of postpartum hemorrhage. The agreement includes €900,000 in milestone payments, as well as royalties paid for 20 years after launch of the product. Successful … [Read more...] about Monash selects Iconovo’s ICOone DPI for its inhaled oxytocin for the prevention of postpartum hemorrhage
Products and Services
Novan selects Catalent for development of intranasal berdazimer sodium
Catalent will supply development services for an intranasal formulation of Novan's berdazimer sodium for COVID-19, the companies said. Berdazimer sodium is a nitric oxide-releasing polymer based on Novan's Nitricil platform, and the company is developing topical gel formulations for the treatment of viral dermatological infections, including molluscum and genital … [Read more...] about Novan selects Catalent for development of intranasal berdazimer sodium
Vectura to add facility for development of highly potent inhaled drugs
CDMO Vectura, which specializes in inhaled drug development and manufacturing, announced that it is adding new product development capabilities for handling highly potent APIs. The new laboratory, which will be located at the company's Chippenham, UK facility, is expected to be ready for use in early 2021. The new lab will have six containment isolators to house … [Read more...] about Vectura to add facility for development of highly potent inhaled drugs
Berry launches RS01X connected DPI
Berry Global has announced the launch of the RS01X connected dry powder inhaler, a new version of its RS01 single dose DPI that integrates with Amiko's Respiro inhaler monitoring platform. The RS01X includes an integral battery and does not require charging, the company said. The Respiro platform, which received the CE mark for use with the Spiromax, Nexthaler, and … [Read more...] about Berry launches RS01X connected DPI
AireHealth gets 510(k) clearance for connected nebulizer
According to Florida-based startup AireHealth, the company has received 510(k) clearance from the FDA for its VitalMed connected portable vibrating mesh nebulizer. Earlier this year, AireHealth acquired BreathResearch and its VitalBreath virtual respiratory health monitoring platform. In 2021, the company said, the VitalMed nebulizer will connect to a new app called … [Read more...] about AireHealth gets 510(k) clearance for connected nebulizer
Kindeva to develop inhaled cannabinoid formulations for BOL Pharma
Kindeva Drug Delivery has announced a new agreement with Israeli medical cannabis company Breath of Life International (BOL Pharma) for development of formulations of several cannabinoids for delivery via Kindeva MDIs. The formulations will initially be for the purpose of feasibility studies. BOL intends to develop the MDIs for the treatment of CND conditions … [Read more...] about Kindeva to develop inhaled cannabinoid formulations for BOL Pharma
Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
US-based startup Kinaset Therapeutics has signed a licensing and develop an inhaled pan-JAK inhibitor that was in Vectura's pipeline prior to that company's transformation into an inhalation CDMO. In July 2019, Vectura announced that it intended to find partners for development of its inhaled drug candidates. The pan-Jak inhibitor, called VR588 by Vectura and now … [Read more...] about Kinaset to develop Vectura inhaled pan-JAK inhibitor for the treatment of asthma
Nanoform introduces nanoforming technology for biologics
Nanoform Finland has announced the launch of new nanonization technology that is capable of creating biological nanoparticles down to 50 nm. The company said that it has filed for US patents covering the technology and currently has two non-GMP lines capable of producing biological nanoparticles for a proof of concept study. Nanoform CTO Niklas Sandler said, "We … [Read more...] about Nanoform introduces nanoforming technology for biologics
MSP launches NGI+ cascade impactor
MSP, a division of TSI, has announced the launch of an enhanced Next Generation Impactor (NGI) called the NGI+, which is designed for improved resistance to corrosion and longer life expectancy. According to MSP, which was acquired by TSI in 2016, existing NGIs can also be upgraded to the new standard. The NGI+'s greater tolerance of harsh conditions makes the … [Read more...] about MSP launches NGI+ cascade impactor
Synairgen turns to Parexel for help with Phase 3 trial of inhaled interferon beta for COVID-19
Parexel announced that Synairgen has signed a collaboration agreement with Parexel Biotech for a Phase 3 trial of Synairgen's SNG001 nebulized interferon-beta-1a for the treatment of COVID-19. In July 2020, Synairgen announced positive results from a Phase 2 trial of SNG001 in COVID-19 patients hospitalized in the UK. The Phase 3 SG018 trial is expected to enroll 900 … [Read more...] about Synairgen turns to Parexel for help with Phase 3 trial of inhaled interferon beta for COVID-19